Single User License
INR 169825
Site License
INR 339650
Corporate User License
INR 509475

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Pompe Disease Global Clinical Trials Review, H1

Pompe Disease Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Pompe Disease Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Pompe Disease Global Clinical Trials Review, H1, 2015" provides an overview of Pompe Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Pompe Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Pompe Disease 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Pompe Disease to Metabolic Disorders Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Pompe Disease to Metabolic Disorders Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Pompe Disease 25

Subjects Recruited Over a Period of Time 26

Clinical Trials by Sponsor Type 27

Prominent Sponsors 28

Top Companies Participating in Pompe Disease Therapeutics Clinical Trials 29

Prominent Drugs 30

Latest Clinical Trials News on Pompe Disease 31

May 04, 2015: Cortex Pharmaceuticals Announces Publication of Research Results on the Use of Ampakines CX1739 in the Treatment of Respiratory Disorders 31

May 04, 2015: Cortex Pharmaceuticals Announces Publication of Research Results on the Use of Ampakines CX717 in the Treatment of Respiratory Disorders 31

Clinical Trial Profiles 32

Clinical Trial Overview of Top Companies 32

Sanofi 32

Clinical Trial Overview of Sanofi 32

Amicus Therapeutics, Inc. 34

Clinical Trial Overview of Amicus Therapeutics, Inc. 34

BioMarin Pharmaceutical Inc. 35

Clinical Trial Overview of BioMarin Pharmaceutical Inc. 35

EPS Corporation 36

Clinical Trial Overview of EPS Corporation 36

Cortex Pharmaceuticals, Inc. 37

Clinical Trial Overview of Cortex Pharmaceuticals, Inc. 37

Audentes Therapeutics, Inc. 38

Clinical Trial Overview of Audentes Therapeutics, Inc. 38

Alexion Pharmaceuticals, Inc. 39

Clinical Trial Overview of Alexion Pharmaceuticals, Inc. 39

Clinical Trial Overview of Top Institutes / Government 40

University of Florida 40

Clinical Trial Overview of University of Florida 40

Erasmus MC 41

Clinical Trial Overview of Erasmus MC 41

Duke University Medical Center 42

Clinical Trial Overview of Duke University Medical Center 42

National Taiwan University Hospital 43

Clinical Trial Overview of National Taiwan University Hospital 43

Five Key Clinical Profiles 44

Appendix 71

Abbreviations 71

Definitions 71

Research Methodology 72

Secondary Research 72

About GlobalData 73

Contact Us 73

Disclaimer 73

Source 73

List of Figures

Pompe Disease Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Pompe Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Pompe Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Pompe Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Pompe Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Pompe Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Pompe Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Pompe Disease Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Pompe Disease to Metabolic Disorders Clinical Trials, G7 Countries (%), 2015* 15

Pompe Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Pompe Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Pompe Disease to Metabolic Disorders Clinical Trials, E7 Countries (%), 2015* 18

Pompe Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Pompe Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Pompe Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Pompe Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Pompe Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Pompe Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Pompe Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27

Pompe Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Pompe Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Pompe Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 72

List of Tables

Pompe Disease Therapeutics, Global, Clinical Trials by Region, 2015* 7

Pompe Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Pompe Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Pompe Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Pompe Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Pompe Disease Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Pompe Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Pompe Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Pompe Disease to Metabolic Disorders Clinical Trials, G7 Countries (%), 2015* 15

Pompe Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Pompe Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Pompe Disease to Metabolic Disorders Clinical Trials, E7 Countries (%), 2015* 18

Pompe Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Pompe Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Pompe Disease Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Pompe Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Pompe Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Pompe Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Pompe Disease Therapeutics, Global, Terminated Clinical Trials, 2015* 25

Pompe Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Pompe Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27

Pompe Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Pompe Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Pompe Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

Pompe Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 32

Pompe Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Amicus Therapeutics, Inc., 2015* 34

Pompe Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by BioMarin Pharmaceutical Inc., 2015* 35

Pompe Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by EPS Corporation, 2015* 36

Pompe Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Cortex Pharmaceuticals, Inc., 2015* 37

Pompe Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Audentes Therapeutics, Inc., 2015* 38

Pompe Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexion Pharmaceuticals, Inc., 2015* 39

Pompe Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2015* 40

Pompe Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2015* 41

Pompe Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University Medical Center, 2015* 42

Pompe Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015* 43

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Sanofi

Amicus Therapeutics, Inc.

BioMarin Pharmaceutical Inc.

EPS Corporation

Cortex Pharmaceuticals, Inc.

Audentes Therapeutics, Inc.

Alexion Pharmaceuticals, Inc.

Pompe Disease Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Pompe Disease, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com